Although several nanomedicines got clinical approval over the past two decades, the clinical
translation rate is relatively small so far. There are many post-surveillance withdrawals of …

Clinical applications of protein therapeutics—an advanced generation of drugs
characterized by high biological specificity—are rapidly expanding. However, their …

Synthetic polymer materials have been surged to the forefront of research in the fields of
tissue engineering, drug delivery, and biomonitoring in recent years. Biodegradable …

Polyphosphazenes, which are inorganic-organic hybrid polymers with Pdouble bondN as
the skeleton, are well-known for their unique physicochemical properties stemming from …

Synthetic polymers are indispensable in biomedical applications because they can be
fabricated with consistent and reproducible properties, facile scalability, and customizable …

Poly (lactide-co-glycolide)(PLGA) nanoparticles (NPs) enhance the delivery of therapeutic
enzymes for replacement therapy of lysosomal storage disorders. Previous studies …

Recent advances in biomedicine necessitate the critical and systematic review of current
trends in the development and modification of biomaterials for biomedical applications …

Advanced multifunctional biomaterials are increasingly relying on clinically dictated patterns
of selectivity against various biological targets. Integration of these frequently conflicting …

Self-assembly of ionically charged small molecule drugs with water-soluble biodegradable
polyelectrolytes into nano-scale complexes can potentially offer a novel and attractive …